Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CD25 TARGETING POLYPEPTIDE, MOLECULAR PROBE AND USE
Document Type and Number:
WIPO Patent Application WO/2023/245852
Kind Code:
A1
Abstract:
Provided are a CD25 targeting polypeptide, a molecular probe and use. An amino acid sequence of the polypeptide is as follows: i) X1X2X3X4X5; or ii) an amino acid sequence formed by connecting a label at an N-terminus or a C-terminus of i), wherein X1 is arginine, lysine, or histidine; X2 is phenylalanine, tyrosine, benzyl tyrosine, or halogenated phenylalanine; X3 is arginine, lysine, or histidine; X4 is phenylalanine, tyrosine, benzyl tyrosine, or halogenated phenylalanine; and X5 is phenylalanine, tyrosine, benzyl tyrosine, or halogenated phenylalanine.

Inventors:
YANG ZHI (CN)
LIU FUTAO (CN)
WANG SHUAILIANG (CN)
ZHU HUA (CN)
WANG PEI (CN)
WANG FENG (CN)
Application Number:
PCT/CN2022/114251
Publication Date:
December 28, 2023
Filing Date:
August 23, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BEIJING CANCER HOSPITAL PEKING UNIV CANCER HOSPITAL (CN)
International Classes:
C07K7/06; A61K51/08; C07K1/13
Domestic Patent References:
WO2016077061A22016-05-19
WO2021183832A12021-09-16
Foreign References:
US20160199524A12016-07-14
CN1478098A2004-02-25
CN111212661A2020-05-29
CN114773433A2022-07-22
Other References:
DATABASE REGISTRY 30 September 2021 (2021-09-30), ANONYMOUS: "INDEX NAME NOT YET A SSIGNED ", XP093118748, retrieved from STN Database accession no. 2703745-80-4
DAMOISEAUX JAN: "The IL-2 – IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor", CLINICAL IMMUNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 218, 1 July 2020 (2020-07-01), AMSTERDAM, NL , XP086241545, ISSN: 1521-6616, DOI: 10.1016/j.clim.2020.108515
Attorney, Agent or Firm:
BEIJING SICHUANG DACHENG INTELLECTUAL PROPERTY AGENCY CO., LTD. (CN)
Download PDF: